Paxlovid (Nirmatrelvir and Ritonavir) Use in Pregnant and Lactating Woman: Current Evidence and Practice Guidelines—A Scoping Review

COVID-19 virus, since the detection of the first case in Wuhan in 2019, has caused a worldwide pandemic with significant human, economic and social costs. Fortunately, several vaccines and treatments, both IV and oral, are currently approved against the COVID-19 virus. Paxlovid is an oral treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Chourasia, Prabal, Maringanti, Babu Sriram, Edwards-Fligner, Morgan, Gangu, Karthik, Bobba, Aniesh, Sheikh, Abu Baker, Shekhar, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866309/
https://www.ncbi.nlm.nih.gov/pubmed/36679952
http://dx.doi.org/10.3390/vaccines11010107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866309/
https://www.ncbi.nlm.nih.gov/pubmed/36679952
http://dx.doi.org/10.3390/vaccines11010107

Ejemplares similares